BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18516626)

  • 1. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases.
    Goilav B; Satlin LM; Wilson PD
    Pediatr Nephrol; 2008 Sep; 23(9):1473-82. PubMed ID: 18516626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
    Vijayakumar S; Dang S; Marinkovich MP; Lazarova Z; Yoder B; Torres VE; Wallace DP
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F640-54. PubMed ID: 24370592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cyst evolution in childhood: a contemporary observational study.
    Rediger C; Guerra LA; Keays MA; Wayne C; Reddy D; Ksara S; Leonard MP
    J Pediatr Urol; 2019 Apr; 15(2):188.e1-188.e6. PubMed ID: 30808538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycystic kidney disease--autopsy review from the period 1987-2007].
    Radojević-Skodrić S; Bogdanović L; Jovanović M; Baralić I; Savin M; Basta-Jovanović G
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():294-7. PubMed ID: 20804098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages promote polycystic kidney disease progression.
    Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
    Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary polycystic kidney diseases in children: changing sonographic patterns through childhood.
    Avni FE; Guissard G; Hall M; Janssen F; DeMaertelaer V; Rypens F
    Pediatr Radiol; 2002 Mar; 32(3):169-74. PubMed ID: 12164348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD).
    Tao Y; Kim J; Stanley M; He Z; Faubel S; Schrier RW; Edelstein CL
    Kidney Int; 2005 Mar; 67(3):909-19. PubMed ID: 15698430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.
    Daïkha-Dahmane F; Narcy F; Dommergues M; Lacoste M; Beziau A; Gubler MC
    Pediatr Nephrol; 1997 Jun; 11(3):267-73. PubMed ID: 9203171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease.
    Ibrahim S
    ScientificWorldJournal; 2007 Nov; 7():1757-67. PubMed ID: 18040538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form.
    Nicolau C; Torra R; Badenas C; Pérez L; Oliver JA; Darnell A; Brú C
    Nephrol Dial Transplant; 2000 Sep; 15(9):1373-8. PubMed ID: 10978393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Scenarios in Chronic Kidney Disease: Cystic Renal Diseases.
    Meola M; Samoni S; Petrucci I
    Contrib Nephrol; 2016; 188():120-30. PubMed ID: 27169740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.